Nitrate tolerance: effect of thiol supplementation during prolonged nitroglycerin infusion in an in vivo rat model

S Boesgaard, JS Petersen, J Aldershvile, HE Poulsen and H Flachs

Department of Internal Medicine B, Rigshospitalet, University of Copenhagen, Denmark.

Depletion of intracellular sulfhydryl groups has been considered a main reason for the development of nitrate tolerance during sustained nitrate therapy. Although administration of N-acetyl-cysteine, a sulfhydryl donor, potentiates the acute hypotensive effect of nitroglycerin (NTG), its role in the reversal of nitrate tolerance is controversial. In the present study, we developed a conscious in vivo rat model to study nitrate tolerance and nitrate-thiol interactions. Tolerance to NTG, as assessed by the blood pressure reduction in response to i.v. NTG bolus doses, developed after 24 h of i.v. NTG infusion. After 3 and 5 days of 0.2 mg/h NTG i.v., the dose-response relations for NTG-induced reduction in blood pressure were shifted to 25-fold higher doses (P less than .01). Infusion of N-acetylcysteine (0.245, 1.225 and 6.125 mmol/kg/h for 4 h) and, to a lesser extent, equimolar doses of reduced glutathione, but not N-acetylserine, significantly potentiated the hypotensive effect of NTG, in a dose- dependent manner (P less than .05). However, complete reversal of tolerance was not achieved. This animal model of nitrate tolerance is suitable for further investigations of nitrate-thiol interactions and shares similarities with nitrate tolerance development in humans. The results suggest that sulfhydryl supplementation may enhance the hypotensive effect of NTG in a dose-dependent manner. This effect is more likely to be achieved with N-acetylcysteine than with glutathione and may be related to differences in membrane permeability.

Volume 258, Issue 3, pp. 851-856, 09/01/1991
Copyright © 1991 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				N. Haramaki, H. Ikeda, Y. Takajo, A. Katoh, S. Kanaya, S. Shintani, R. Haramaki, T. Murohara, and T. Imaizumi Long-Term Smoking Causes Nitroglycerin Resistance in Platelets by Depletion of Intraplatelet Glutathione Arterioscler. Thromb. Vasc. Biol., November 1, 2001; 21(11): 1852 - 1856. [Abstract] [Full Text] [PDF]

				L. Bang, S. Boesgaard, J. E. Nielsen-Kudsk, N. G. Vejlstrup, and J. Aldershvile Nitroglycerin-mediated vasorelaxation is modulated by endothelial calcium-activated potassium channels Cardiovasc Res, August 15, 1999; 43(3): 772 - 778. [Abstract] [Full Text] [PDF]

				J. B. Laursen, A. Mulsch, S. Boesgaard, P. Mordvintcev, S. Trautner, N. Gruhn, J. E. Nielsen-Kudsk, R. Busse, and J. Aldershvile In Vivo Nitrate Tolerance Is Not Associated With Reduced Bioconversion of Nitroglycerin to Nitric Oxide Circulation, November 1, 1996; 94(9): 2241 - 2247. [Abstract] [Full Text]